About Cerium Pharmaceuticals
Cerium Pharmaceuticals is a private company based in Gaithersburg, Maryland. It has reported $13,829,113 raised in four offerings on Form D since June 2016. Its chief executive is Gregg Lapointe.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 22, 2026 | Aug 6, 2026 | $750,000of $2.5M target | 4 | $187K | EquityRule 506(b) | Form D ↗ |
| Jul 22, 2021 | Jul 30, 2021 | $8,900,000of $10.0M target | 5 | $1.7M | EquityRule 506(b) | Form D ↗ |
| Mar 26, 2021 | May 25, 2021 | $1,905,432fully sold | 9 | $211K | DebtRule 506(b) | Form D ↗ |
| Jun 13, 2016 | Jun 27, 2016 | $2,273,681of $7.2M target | 9 | $252K | Equity, OptionsRule 506(c) | Form D ↗ |
| Total, four offerings | $13,829,113 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cerium Pharmaceuticals's Form D filed Aug 6, 2026.
SE
Steve Eskenazi
Director
PC
Peter Collum
Director
James Gale
Board Member
Robert Rubin
Co-Founder, Interim CMO and director
Earlier filings also listed Nancy Klett (executive officer, last listed Jul 2021).